Project Grant R33HL163749
- Dynocardia Inc. received a $256,000 National Science Foundation Project Grant to advance development of a novel continuous, cuffless blood pressure monitoring device. Funded through the NSF Engineering Directorate's SBIR program, the award will support Dynocardia's efforts to address motion artifacts and enable accurate, beat-to-beat blood pressure measurements in hospital intensive care and operating room settings. Accurate 24-hour blood pressure monitoring has potential to significantly...
- The National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research federal grant program (CFDA 93.837), awarded a $306,872 project grant to Vena Vitals Inc., a women-owned small business in Irvine, California. The grant funding supports the development of "VeriSleep", a wearable device that can provide continuous, non-invasive monitoring of cardiovascular biomarkers during sleep. The goal is to create a robust, cost-effective solution that can capture...
- This federal Project Grant award of $649,678, provided by the National Heart Lung and Blood Institute under the Cardiovascular Diseases Research program (CFDA 93.837), supports the development of a high-speed, wearable speckle contrast optical spectroscopy (SCOS) system for cuffless blood pressure monitoring. The project aims to convert the existing benchtop SCOS technology into a wearable device capable of multi-hour ambulatory monitoring, and to test the technique in a wider range of subjects,...
- This Project Grant award from the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865) provides $237,827 to Brigham & Women's Hospital Inc. to develop a wearable, non-invasive optical device for continuous blood pressure monitoring in neonates. The device, called CNAP-FlexNIRS, will use near-infrared spectroscopy and photoplethysmography to collect high-resolution pulsatile waveforms and...
- Ovid BP Systems Inc. received a $713,199 Project Grant award from the National Institutes of Health's National Heart, Lung and Blood Institute on April 15, 2021 to develop a blood pressure monitoring system using video recording on smart cameras. The goal of the Cardiovascular Diseases Research program, CFDA #93.837, is to support heart and vascular research. Under this award, Ovid BP will assess the feasibility of using video-based algorithms to accurately measure blood pressure through...
- This $200,000 Project Grant awarded by the National Science Foundation (NSF) Division of Electrical, Communications and Cyber Systems under CFDA 47.041 (Engineering) aims to develop and implement a novel testing platform to evaluate the accuracy of wearable photoplethysmography-based blood pressure monitoring devices. The University of Maryland, College Park will construct a bench flow phantom that simulates physiologically relevant blood pressure, blood flow, anatomical, and optical...
- The National Heart, Lung, and Blood Institute (NHLBI) awarded a $583,718 Project Grant to Berendo Scientific LLC under the Cardiovascular Diseases Research program (CFDA 93.837) to optimize and evaluate the SLEEPFLEX head and neck exercise program for the treatment of mild to moderate obstructive sleep apnea (OSA). The project aims to develop a focused, effective, safe, and non-invasive head and neck exercise program delivered via a smartphone app to increase the strength and endurance of key...
- The National Heart, Lung, and Blood Institute (NHLBI) awarded a $349,734 Project Grant under the Cardiovascular Diseases Research program (CFDA 93.837) to Actiox LLC, a biomedical technology company in Thousand Oaks, California. The project aims to develop a wearable microneedle-based biosensor for continuous, real-time cardiac troponin I monitoring. The goal is to demonstrate the feasibility of this transformative biosensor technology to enable earlier detection of ischemic events and...
- This Project Grant award from the National Heart, Lung, and Blood Institute (CFDA 93.837 - Cardiovascular Diseases Research) aims to elucidate the complex relationship between obstructive sleep apnea (OSA) and cardiovascular disease (CVD). The $1,296,660 award supports a 24-month research project that will employ a "bed to bench" approach integrating clinical, computational, and in vitro techniques. Key objectives include developing and validating a mathematical model to quantify...
- This federal Project Grant award, valued at $678,710 and awarded on June 15, 2025, was provided by the National Heart, Lung, and Blood Institute under the Cardiovascular Diseases Research program (CFDA 93.837). The award supports the development and validation of a novel multi-sensor machine learning approach to precision sleep tracking for nightshift workers. The project aims to leverage wearable devices, environmental sensors, and machine learning algorithms to accurately detect sleep patterns...
BEAT-TO-BEAT BLOOD PRESSURE MONITORING DURING SLEEP - PROJECT SUMMARY THE PROJECT AIMS TO ADVANCE A PROTOTYPE DEVICE FOR CONTINUOUS NON-INVASIVE BLOOD PRESSURE (BP) MONITORING INTO A VERSATILE PLATFORM TECHNOLOGY FOR BEAT-TO-BEAT BP MONITORING DURING SLEEP. NOCTURNAL BP HAS BEEN SHOWN TO BE A STRONGER PREDICTOR OF CARDIOVASCULAR EVENTS THAN DAYTIME BP. HOWEVER, THE TRADITIONAL METHOD FOR MONITORING BP DURING SLEEP IS WITH AMBULATORY BP MONITORING (ABPM), WHICH IS UNCOMFORTABLE TO WEAR, DISTURBS SLEEP, AND ONLY PROVIDES INTERMITTENT MEASUREMENTS. A PLATFORM TECHNOLOGY THAT ACCURATELY AND COMFORTABLY MONITORS BEAT-TO-BEAT BP AND BP VARIABILITY DURING SLEEP IS NEEDED TO BETTER CHARACTERIZE THE COMPLEX RELATIONSHIP BETWEEN SLEEP DISORDERS AND CARDIOVASCULAR HEALTH. FOR EXAMPLE, BP SURGES ASSOCIATED WITH APNEIC AND HYPOPNEIC EVENTS IN OBSTRUCTIVE SLEEP APNEA OCCUR OVER A PERIOD OF SECONDS AND GO UNDETECTED BY ABPM MONITORS. QUANTIFICATION OF THE EFFECTS THAT SLEEP DISORDERS HAVE ON HEMODYNAMIC FUNCTION CAN POTENTIALLY LEAD TO NEW BIOMARKERS, IMPROVED DIAGNOSTICS, AND PERSONALIZED TREATMENT AND MANAGEMENT. PRIOR ATTEMPTS AT CUFFLESS NON-INVASIVE TECHNOLOGIES FALL INTO SEVERAL CATEGORIES (FINGER VOLUME CLAMP, PULSE TRANSIT TIME, PULSE DECOMPOSITION ANALYSIS, TONOMETRY, AND COMBINATIONS THEREOF), BUT ALL HAVE EXPERIENCED DISTINCT LIMITATIONS IN ACCURACY, USABILITY, OR COST, THEREBY PREVENTING WIDESPREAD CLINICAL ADOPTION. OUR TECHNOLOGY OVERCOMES THESE LIMITATIONS. FIRST, OUR TECHNOLOGY ACHIEVES HIGH ACCURACY DUE TO THE SOFT ELASTOMERIC PROPERTIES THAT ALLOW CONFORMAL CONTACT OF OUR SENSORS TO THE SKIN'S SURFACE, DETECTING HIGH RESOLUTION SIGNALS AND DYNAMIC FLUCTUATIONS IN THE ARTERIAL WAVEFORM. SECOND, OUR DEVICES ARE LOW-COST AND CAN BE FABRICATED USING ROLL-TO-ROLL PROCESSES THAT DO NOT REQUIRE PHOTOLITHOGRAPHY OR CLEAN ROOMS, AND HAVE LOW POWER CONSUMPTION THAT CAN BE SUPPORTED WITH COMMON ELECTRICAL COMPONENTS. FINALLY, OUR TECHNOLOGY ENSURES USABILITY THROUGH A LOW-PROFILE SYSTEM THAT IS COMFORTABLE TO WEAR OVER LONG PERIODS, SUCH AS DURING SLEEP. IN THIS PROJECT, WE WILL DEVELOP AND VALIDATE THE BEAT-TO-BEAT BP MONITOR TO BE USED DURING SLEEP. WE WILL DEVELOP THE HARDWARE, FIRMWARE, AND ALGORITHMS NECESSARY TO MAINTAIN THE ACCURACY OF THE MONITORED BLOOD PRESSURE THROUGHOUT THE SLEEP CYCLE WHILE CORRECTING FOR MOTION AND HOLDING THE CALIBRATION. WE WILL VALIDATE OUR PROTOTYPE THROUGH CLINICAL TESTING AND CORRELATE DETECTED BP EVENTS TO SLEEP STUDY PARAMETERS. THIS WILL BE THE FIRST OF ITS KIND TECHNOLOGY THAT NOT ONLY WILL IMPROVE HOW NOCTURNAL BP IS MONITORED, DIAGNOSED, AND MANAGED TO IMPROVE CARDIOVASCULAR HEALTH, BUT ALSO SERVE AS A PLATFORM TO ENABLE NEW DIRECTIONS IN CLINICAL RESEARCH AND UNDERSTANDING OF CARDIOVASCULAR FUNCTION IN SLEEP.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $0 | 9/4/25 | ||
| Not listed | $427.2k | 6/8/23 | ||
| Not listed | $415.6k | 5/26/22 | ||
| Not listed | $415.6k | 5/26/22 |